当科での研究

2022年

  1. Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y, Tatetsu H, Yuichiro Nawa, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R. Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study. Int J Hematol. 2022; 115 (3): 382-390.
    PMID: 34981434

2021年

  1. Wanitpongpun C, Honma Y, Okada T, Suzuki R, Urano T, Suzumiya J. Tamoxifen enhances romidepsin-induced apoptosis in T-cell malignant cells via activation of FOXO1 signaling pathway. Leuk Lymphoma. 56 (6): 1462-1466, 2021.
    PMID: 33508992
  2. Fujimoto A, Anzai T, Fukuda T, Uchida N, Ohta T, Mori T, Sawa M, Yoshioka S, Miyamoto T, Uchiyama H, Katayama Y, Matsuoka K, Shiratori S, Nakazawa H, Kanda J, Ichinohe T, Atsuta Y, Fujita N, Kondo E, Suzuki R. Impact of event-free survival status after stem cell transplantation on subsequent survival in lymphoma patients. Blood Adv. 5 (5): 1412-1424, 2021.
    PMID: 33666656
  3. Takahashi T, Suzuki R, Yamamoto G, Nakazawa H, Kurosawa M, Kobayashi T, Okada M, Akasaka T, Kim SW, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J. Hematopoietic stem cell transplantation for diffuse large B-cell lymphoma having 8q24/MYC rearrangement in Japan. Hematol Oncol. 39 (1): 66-74, 2021.
    PMID: 32979280
  4. Fujimoto A, Ikejiri F, Arakawa F, Ito S, Okada Y, Takahashi F, Matsuda S, Okada T, Inoue M, Takahashi T, Miyake T, Maruyama R, Ohshima K, Suzumiya J, Suzuki R. Simultaneous discordant B-lymphoblastic lymphoma and follicular lymphoma: lymphoblastic transformation with MYC translocation. Am J Clin Pathol. 155 (2): 308-317, 2021.
    PMID: 32915189
  5. Fujimoto A, Ishida F, Izutsu K, Yamasaki S, Chihara D, Suzumiya J, Mitsui T, Doki N, Sakai H, Kobayashi H, Kanda J, Fukuda T, Atsuta Y, Suzuki R, on behalf of the Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia. Bone Marrow Transplant. 56 (2): 347-356, 2021.
    PMID: 32778688

2020年

  1. Matsuda S, Suzuki R, Takahashi T, Suehiro Y, Tomita N, Izutsu K, Fukuhara N, Imaizumi Y, Shimada K, Nakazato T, Yoshida I, Miyazaki K, Yamaguchi M, Suzumiya J. Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data. Int J Hematol. 2020; 112 (6): 807-816.
    PMID: 32880824
  2. Fujimoto A, Suzuki R, Orihara K, Iida M, Yamashita T, Nagafuji K, Kanamori H, Kodera Y, Miyamura K, Okamoto S, Hino M. Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan. Int J Hematol. 2020; 111 (6): 840-850.
    PMID: 32172446
  3. Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Sugio Y, Fukuda T, Uchida N, Ikegame K, Matsuoka K, Shiratori S, Kondo T, Miyamoto T, Eto T, Ichinohe T, Kanda Y, Atsuta Y, Suzuki R. Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. Hematol Oncol. 2020; 38 (2): 146-152.
    PMID: 31953867

共同研究

2022年

  1. Miyazaki K, Suzuki R, Oguchi M, Taguchi S, Amaki J, Maeda T, Kubota N, Maruyama D, Terui Y, Sekiguchi N, Takizawa J, Tsukamoto H, Murayama T, Ando T, Matsuoka H, Hasegawa M, Wada H, Sakai R, Kameoka Y, Tsukamoto N, Choi I, Masaki Y, Shimada K, Fukuhara N, Utsumi T, Uoshima N, Kagami Y, Asano N, Ejima Y, Katayama N, Yamaguchi M. Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma. Hematol Oncol. 2022 Feb 10. doi: 10.1002/hon.2977. Epub ahead of print.
    PMID: 35142384
  2. Onizuka M, Fujii N, Nakasone H, Ogata M, Atsuta Y, Suzuki R, Uchida N, Ohashi K, Ozawa Y, Eto T, Ikegame K, Nakamae H, Inoue M, Fukuda T; Transplant Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation. Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2022; 115 (4): 534-544.
    PMID: 35088350
  3. Hiramoto N, Yamazaki H, Nakamura Y, Uchida N, Murata M, Kondo T, Yoshioka S, Eto T, Nishikawa A, Kimura T, Ichinohe T, Atsuta Y, Onishi Y, Suzuki R, Mori T; Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Ann Hematol. 2022; 101 (1): 165-175.
    PMID: 34546409

2021年

  1. Wierda WG, Rawstron A, Cymbalista F, Badoux X, Rossi D, Brown JR, Egle A, Abello V, Ceballos EC, Herishanu Y, Mulligan SP, Niemann CU, Diong CP, Soysal T, Suzuki R, Tran HTT, Wu S-J, Owen C, Stilgenbauer S, Ghia P, Hillmen P. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations. Leukemia. 2021; 35 (11): 3059-3072.
    PMID: 34168283
  2. Nishida T, Kobayashi T, Sawa M, Masuda S, Shibasaki Y, Goto T, Fukuhara N, Fujii N, Ikegame K, Sugita J, Ikeda T, Kuwatsuka Y, Suzuki R, Najima Y, Doki N, Kato T, Inagaki Y, Utsu Y, Aotsuka N, Masuko M, Terakura S, Onishi Y, Maeda Y, Okada M, Teshima T, Murata M. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin. Ann Hematol. 2021; 100 (3): 743-752.
    PMID: 33427909
  3. Miura K, Tsujimura H, Masaki Y, Iino M, Takizawa J, Maeda Y, Yamamoto K, Tamura S, Yoshida A, Yagi H, Yoshida I, Kitazume K, Masunari T, Choi I, Kakinoki Y, Suzuki R, Yoshino T, Nakamura S, Hatta Y, Yoshida T, Kanno M. Consolidation with 90Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma. Hematol Oncol. 2021; 39 (1): 51-59.
    PMID: 32978820

総説

  1. Fujimoto A, Suzuki R. Progress in the treatment of NK-cell lymphoma/leukemia. J Cancer Metastasis Treat. 7: 66, 2021.
  2. Fujimoto A, Suzuki R. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: pathogenesis, risk factors and clinical outcomes. Cancers. 12 (2): 328, 2020.
    PMID: 32024048
  3. Yamaguchi M, Suzuki R. JSH practical guidelines for hematological malignancies: Peripheral T-cell lymphoma (PTCL). Int J Hematol. 109 (2): 137-140, 2019.
  4. Xavier A, Suzuki R. Treatment and prognosis of mature (non-anaplastic) T- and NK-cell lymphomas in childhood, adolescents, and young adults. Br J Haematol. 185 (6): 1086-1098, 2019.
    PMID: 30706440
  5. Yamaguchi M, Suzuki R. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL). Int J Hematol. 109 (4): 371-376, 2019.

 

著書

  1. Kim SJ, Suzuki R, Jaccard A, Lim ST, Kim WS. Natural killer/T-cell lymphomas. In The Peripheral T-cell Lymphomas (edited by O’Connor OA, Kim WS and Zinzani PL), Wiley-Blackwll, USA, pp. 159-173, 2021.  Blackwell
  2. Wanitpongpun C, Suzuki R: Extranodal NK/T cell lymphomas and EBV+ lymphoproliferative diseases of childhood. In Non-Hodgkin Lymphomas in Childhood and Adolescence. Section VI: Mature T-Non-Hodgkin Lymphomas (edited by Abla O and Attarbaschi A), Springer International Publishing AG, Switzerland, pp. 271-279, 2019.  Splinger
  3. Suzuki R: Extranodal NK/T cell lymphoma, nasal type. In Tropical Hemato-Oncology (edited by Droz J-P, Carme B, Couppié P, Nacher M, Tiéblemont C), Springer International Publishing AG, Switzerland, pp. 199-212, 2015.  Splinger